Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization
03/23/2020 | Heart disease is the leading cause of death in the US; coronary artery disease is the most common type of heart disease.
Circulation: Cardiovascular Quality and Outcomes Just Published on COVID-19
03/19/2020 | Circulation: Cardiovascular Quality and Outcomes Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment?Elevation Myocardial Infarction Care in Hong Kong, China
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Sudden Cardiac Arrest Survivorship
02/12/2020 | With improved systems of care that more fully involve community and healthcare professionals, the number of people surviving cardiac arrest is increasing.
CIRCULATION: CARDIOVASCULAR INTERVENTIONS | Twitter Journal Club | February 2
01/30/2020 | Circulation: Cardiovascular Interventions, Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
HYPERTENSION | Editor's Picks | January 2020
01/24/2020 | Hypertension Trending Topics for January 2020